The EpiPen brand of epinephrine for allergic reactions is on back order due to a recall. To help alleviate the burden of the shortage, the FDA recently extended the expiration dates of certain lots of EpiPens.
The indicated lots are deemed safe for an additional four months, according to the FDA. They hope this decision will help to mitigate the shortage during back-to-school season.
In addition to EpiPens, there are alternative epinephrine autoinjectors available, such as Adrenaclick and Auvi-Q. The FDA also approved the generic EpiPen, but it will not be available for a few months.
For more information
Contact Suburban Pediatrics if you have any questions about your child’s autoinjector.